Business Wire

SunOpta Announces Third Quarter Fiscal 2023 Financial Results

Revenue from continuing operations increased 5.9% to $152.5 million, driven by 5.5% volume growth

Loss from continuing operations of $5.7 million, compared to earnings of $2.4 million in the prior year

Adjusted EBITDA from continuing operations increased 8.1% to $19.1 million

Maintains Q4 outlook for continuing operations and provides 2024 outlook

MINNEAPOLIS--(BUSINESS WIRE)--SunOpta Inc. (“SunOpta” or the “Company”) (Nasdaq:STKL) (TSX:SOY), a U.S.-based global pioneer fueling the future of sustainable, plant-based foods and beverages, today announced financial results for the third quarter ended September 30, 2023.



All amounts are expressed in U.S. dollars and results are reported in accordance with U.S. GAAP, except where specifically noted.

Third Quarter 2023 highlights:

  • Revenues of $152.5 million increased 5.9% compared to $144.0 million in the year earlier period, driven by 5.5% volume growth.
  • Gross profit margin was 13.3% on a reported basis. Excluding start-up costs, gross margin was 16.4%, down 140 basis points from 17.8% mainly due to the 150 basis point increase in depreciation related to new production equipment.
  • Loss from continuing operations was $5.7 million compared to earnings of $2.4 million in the prior year period.
  • Adjusted earnings¹ from continuing operations attributable to common shareholders was $0.5 million or $0.00 per diluted common share, compared to adjusted earnings of $2.4 million or $0.02 per diluted common share in the prior year period.
  • Adjusted EBITDA¹ from continuing operations of $19.1 million, or 12.5% of revenues, compared to $17.7 million and 12.3% of revenues in the prior year period.

“We delivered strong volume-driven revenue growth in the third quarter from protein shakes, oat milk and snacks,” said Joe Ennen, SunOpta Chief Executive Officer. “In addition, the divestiture of our frozen fruit operations subsequent to the end of the quarter was a major strategic milestone that significantly optimizes our product portfolio for growth and profitability along with helping to reduce debt and strengthen our balance sheet, which creates opportunities for capital allocation beneficial to shareholders, including the potential adoption of a share repurchase program. Key growth initiatives continue to advance including market share gains with existing customers, new customers and total addressable market expansion. We are also in the process of replacing our existing asset-based lending arrangement, supplemented with third-party extended payable facilities and finance leases, with a term loan and revolver structure with limited finance leases, which we expect will be in place by the end of the year. With our strong foundation, leverageable platform and expanding capacity, we are confident in our direction and believe that we remain well positioned to deliver significant long-term sustainable growth and value for shareholders.”

Third Quarter 2023 Results

Revenues from continuing operations increased 5.9% to $152.5 million for the third quarter of 2023. The increase was driven by a favorable volume/mix which was up 5.5% and pricing which was up 0.4%. Volume/mix reflected volume growth from oat milks and creamers, 330-milliliter protein shakes and teas, as well as increased sales volumes for fruit snacks, partially offset by lower external sales of plant-based ingredients, due to increased internal demand for oat base and softer demand for almond beverages.

Gross profit was $20.3 million for the third quarter, compared to $25.1 million in the prior year period. As a percentage of revenues, gross profit margin was 13.3% compared to 17.4% in the third quarter of 2022, a decrease of 410 basis points, as reported. Excluding the impact of start-up costs related to the new plant in Midlothian, Texas, and new extrusion line at the fruit snacks facility in Omak, Washington, adjusted gross margin was 16.4% in the third quarter of 2023, compared to 17.8% in the third quarter of 2022. The 140-basis point decline in adjusted gross margin reflected the impact of incremental depreciation of new production equipment for capital expansion projects and higher manufacturing costs partially offset by a positive mix shift in plant-based ingredients with increased internal use.

Operating income¹ was $1.5 million, or 1.0% of revenue in the third quarter of 2023, compared to operating income of $6.6 million, or 4.6% of revenues in the third quarter of 2022. The decrease in operating income was driven by lower gross profit, higher business development and employee severance costs in conjunction with the divestiture of Frozen Fruit and related consolidation of continuing operations, partially offset by lower employee incentive compensation accruals and variable stock-based compensation expenses.

Loss from continuing operations for the quarter ended September 30, 2023 was $5.7 million, compared with earnings of $2.4 million for the quarter ended October 1, 2022. Diluted loss per share from continuing operations attributable to common shareholders (after dividends and accretion on preferred stock) was $0.05 for the quarter ended September 30, 2023, compared with a diluted earnings per share of $0.01 for the quarter ended October 1, 2022.

Loss from discontinued operations was $140.1 million (diluted loss per share of $1.21) for the quarter ended September 30, 2023, compared with $14.3 million (diluted loss per share of $0.13) for the quarter ended October 1, 2022. The increase in the loss from discontinued operations reflected the estimated pre-tax loss on the divestiture of Frozen Fruit of $118.8 million recognized in the third quarter of 2023, compared with a pre-tax loss on the divestiture of Sunflower of $23.2 million recorded in the third quarter of 2022. In addition, the increase in the loss from discontinued operations reflected a period-over-period decrease in the gross profit of Frozen Fruit prior to the divestiture due to lower sales and production volumes as a result of softer retail consumption trends and lost foodservice distribution, together with inventory reserves recognized in connection with the divestiture.

Adjusted earnings¹ in the third quarter of 2023 was $0.5 million or $0.00 per diluted common share, compared to adjusted earnings of $2.4 million or $0.02 per diluted common share in the third quarter of 2022.

Adjusted EBITDA¹ from continuing operations was $19.1 million or 12.5% of revenue in the third quarter of 2023, compared to $17.7 million or 12.3% of revenue in the third quarter of 2022.

Please refer to the discussion and table below under “Non-GAAP Measures”.

Balance Sheet and Cash Flow

As of September 30, 2023, SunOpta had total assets of $746.7 million (including $142.1 million of assets held-for-sale related to the divestiture of Frozen Fruit) and total debt of $314.8 million compared to total assets of $855.9 million and total debt of $308.5 million at year end fiscal 2022. During the third quarter of 2023, cash used in operating activities of continuing operations was $25.9 million compared to cash provided of $9.3 million during the third quarter of 2022. The increase in cash used mainly reflected the impact of start-up costs related to our Midlothian, Texas, facility, and higher cash interest expense on borrowings to finance capital expenditures, together with increases in working capital mainly due to the timing of accounts receivable and payables. Investing activities of continuing operations consumed $4.7 million of cash during the third quarter of 2023 versus $37.3 million in the prior year. The year-over-year decrease reflected the completion of certain major capital projects, including the construction of our new plant-based beverage facility in Midlothian, Texas.

Divestiture of Frozen Fruit

On October 12, 2023, the Company entered into an Asset Purchase Agreement with Natures Touch Mexico, S. de R.L. de C.V. and Nature’s Touch Frozen Fruits, LLC to sell certain assets and liabilities of Frozen Fruit for an aggregate purchase price of approximately $141 million, subject to closing working capital adjustments. The transaction closed on October 12, 2023 (the “Closing Date”). The transaction represents the Company’s exit from the processing, packaging and selling of individually quick frozen fruit for retail, foodservice and industrial applications. Frozen Fruit was previously identified as a reporting unit within the Company’s former Fruit-Based Foods and Beverages operating and reportable segment.

At the Closing Date, the estimated aggregate purchase price was comprised of cash consideration of $95.3 million; a short-term note receivable of $10.5 million; secured seller promissory notes due in three years with a stated principal amount of $20.0 million in the aggregate; and the assumption by the purchasers of $15.7 million of accounts payable and accrued liabilities of Frozen Fruit. At the Closing Date, $20.5 million of the cash consideration was used to make required repayments of certain bank loans and other liabilities of Frozen Fruit not assumed by the purchasers. The Company utilized the remaining cash consideration of $74.8 million to repay a portion of the outstanding borrowings under its revolving credit facilities.

2023 Outlook2

For fiscal 2023, the Company maintains its outlook, adjusting for the divestiture of Frozen Fruit:

($ millions)

Previous 2023 Consolidated Outlook

2023 Frozen

Fruit Outlook

2023 Continuing Operations Outlook

Revenue

$

880 - 900

$

266 - 270

$

614 - 630

Adj. EBITDA

$

87 - 91

$

12 – 14

$

75 – 77

Revenue growth

(6%) – (4%)

4% - 7%

Adj. EBITDA growth

4% - 9%

18% - 21%

2024 Outlook2

For fiscal 2024, the Company expects strong revenue growth, driven by volume and strong adjusted EBITDA growth:

($ millions)

 

2024 Outlook

 

 

Growth*

Revenue

$

670 – 700

 

8% - 13%

Adj. EBITDA

$

87 - 92

 

14% - 21%

*Expected growth based on the midpoint of the range of the 2023 outlook

Conference Call

SunOpta plans to host a conference call at 5:30 P.M. Eastern time on Wednesday, November 8, 2023, to discuss the third quarter financial results. After opening remarks, there will be a question-and-answer period. Investors interested in listening the live webcast can access a link on SunOpta's website at www.sunopta.com under the “Investor Relations” section or directly here. A replay of the webcast will be archived and can be accessed for approximately 90 days on the Company's website. This call may be accessed with the toll free dial-in number dial (888) 440-4182 or International dial-in number (646) 960-0653 using Conference ID: 8338433.

¹ See discussion of non-GAAP measures

2 The Company has included certain forward-looking statements about the future financial performance that include non-GAAP financial measures, including Adjusted EBITDA. These non–GAAP financial measures are derived by excluding certain amounts, expenses or income, from the corresponding financial measures determined in accordance with GAAP. The determination of the amounts that are excluded from these non-GAAP financial measures is a matter of management judgment and depends upon, among other factors, the nature of the underlying expense or income amounts recognized in a given period. We are unable to present a quantitative reconciliation of the aforementioned forward-looking non-GAAP financial measures to their most directly comparable forward-looking GAAP financial measures because management cannot reliably predict all of the necessary components of such GAAP measures. Historically, management has excluded the following items from certain of these non-GAAP measures, and such items may also be excluded in future periods and could be significant amounts.

  • Expenses related to the acquisition or divestiture of a business, including business development costs, impairment of assets, integration costs, severance, retention costs and transaction costs;
  • Start-up costs of new facilities and equipment;
  • Charges associated with restructuring and cost saving initiatives, including but not limited to asset impairments, accelerated depreciation, severance costs and lease abandonment charges;
  • Asset impairment charges and facility closure costs;
  • Legal settlements or awards; and
  • The tax effect of the above items.

About SunOpta Inc.

SunOpta (Nasdaq:STKL) (TSX:SOY) is a U.S.-based, global pioneer fueling the future of sustainable, plant-based food and beverages. Founded nearly 50 years ago, SunOpta manufactures natural, organic and specialty products sold through retail and foodservice channels. SunOpta operates as a manufacturer for leading natural and private label brands, and also proudly produces its own brands, including SOWN ®, Dream®, and West LifeTM. For more information, visit www.sunopta.com, LinkedIn and Twitter.

Forward-Looking Statements

Certain statements included in this press release may be considered "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation, which are based on information available to us on the date of this release. These forward-looking statements include, but are not limited to, the potential adoption of a share repurchase program, replacement of our existing asset-based lending arrangement by the end of the year, our belief that we are well positioned to deliver significant long-term sustainable growth and value for shareholders, our expectation for strong revenue growth for fiscal 2024 and our anticipated Revenue, Adjusted EBITDA , Revenue growth and Adjusted EBITDA growth for fiscal 2023 and our anticipated Revenue and Adjusted EBITDA for fiscal 2024. Generally, forward-looking statements do not relate strictly to historical or current facts and are typically accompanied by words such as “potential”, “expect”, “believe”, “anticipate”, “estimates”, “can”, “will”, “target”, "should", "would", "plans", “continue”, "becoming", "intend", "confident", "may", "project", "intention", "might", "predict", “budget”, “forecast” or other similar terms and phrases intended to identify these forward-looking statements. Forward-looking statements are based on information available to the Company on the date of this release and are based on estimates and assumptions made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments including, but not limited to, the Company’s actual financial results; our exit from, and use of proceeds from the divestiture of the assets and liabilities of, Frozen Fruit, uninterrupted operations and service levels to our customers; current customer demand for the Company’s products; general economic conditions; continued consumer interest in health and wellness; the Company’s ability to maintain product pricing levels; planned facility and operational expansions, closures and divestitures; cost rationalization and product development initiatives; alternative potential uses for the Company’s capital resources; portfolio optimization and productivity efforts; the sustainability of the Company’s sales pipeline; the Company’s expectations regarding commodity pricing, margins and hedging results; procurement and logistics savings; freight lane cost reductions; yield and throughput enhancements; the cost of the frozen fruit recall; labor cost reductions; and the terms of our insurance policies. Whether actual timing and results will agree with expectations and predictions of the Company is subject to many risks and uncertainties including, but not limited to, potential loss of suppliers and customers as well as the possibility of supply chain, logistics and other disruptions; unexpected issues or delays with the Company’s structural improvements and automation investments; failure or inability to implement portfolio changes, process improvements, go-to-market improvements and process sustainability strategies in a timely manner; changes in the level of capital investment; local and global political and economic conditions; consumer spending patterns and changes in market trends; decreases in customer demand; delayed or unsuccessful product development efforts; potential product recalls; potential additional costs associated with the frozen fruit recall; working capital management; availability and pricing of raw materials and supplies; potential covenant breaches under the Company’s credit facilities; and other risks described from time to time under "Risk Factors" in the Company's Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q (available at www.sec.gov). Consequently, all forward-looking statements made herein are qualified by these cautionary statements and there can be no assurance that the actual results or developments anticipated by the Company will be realized. The Company undertakes no obligation to publicly correct or update the forward-looking statements in this document, in other documents, or on its website to reflect future events or circumstances, except as may be required under applicable securities laws.

 
 

SunOpta Inc.

Consolidated Statements of Operations

For the quarters and three quarters ended September 30, 2023 and October 1, 2022

(Unaudited)

(All dollar amounts expressed in thousands of U.S. dollars, except per share amounts)

 

 

Quarter ended

Three quarters ended

 

September 30, 2023

October 1, 2022

September 30, 2023

October 1, 2022

 

$

$

$

$

 

 

 

 

Revenues

152,541

 

144,023

 

448,673

 

431,605

 

 

 

 

 

Cost of goods sold

132,273

 

118,891

 

385,697

 

355,691

 

 

 

 

 

Gross profit

20,268

 

25,132

 

62,976

 

75,914

 

 

 

 

 

Selling, general and administrative expenses

18,377

 

17,866

 

58,403

 

58,864

 

Intangible asset amortization

446

 

446

 

1,338

 

1,338

 

Other expense (income), net

-

 

451

 

(20

)

1,408

 

Foreign exchange loss (gain)

(37

)

(223

)

44

 

(208

)

 

 

 

 

 

Operating income

1,482

 

6,592

 

3,211

 

14,512

 

 

 

 

 

 

Interest expense, net

7,162

 

3,901

 

19,391

 

8,844

 

 

 

 

 

 

Earnings (loss) from continuing operations before income taxes

(5,680

)

2,691

 

(16,180

)

5,668

 

 

 

 

 

 

Income tax expense

-

 

332

 

3,978

 

1,360

 

 

 

 

 

 

Earnings (loss) from continuing operations

(5,680

)

2,359

 

(20,158

)

4,308

 

Loss from discontinued operations

(140,143

)

(14,293

)

(143,126

)

(10,203

)

Net loss

(145,823

)

(11,934

)

(163,284

)

(5,895

)

 

 

 

 

 

Dividends and accretion on preferred stock

(426

)

(764

)

(1,552

)

(2,279

)

 

 

 

 

 

Loss attributable to common shareholders

(146,249

)

(12,698

)

(164,836

)

(8,174

)

 

 

 

 

 

Basic earnings (loss) per share

 

 

 

 

Earnings (loss) from continuing operations

(0.05

)

0.01

 

(0.19

)

0.02

 

Loss from discontinued operations

(1.21

)

(0.13

)

(1.26

)

(0.09

)

Loss attributable to common shareholders(1)

(1.26

)

(0.12

)

(1.45

)

(0.08

)

 

 

 

 

 

Diluted earnings (loss) per share

 

 

 

 

Earnings (loss) from continuing operations

(0.05

)

0.01

 

(0.19

)

0.02

 

Loss from discontinued operations

(1.21

)

(0.13

)

(1.26

)

(0.09

)

Loss attributable to common shareholders(1)

(1.26

)

(0.12

)

(1.45

)

(0.08

)

 

 

 

 

 

Weighted-average common shares outstanding (000s)

 

 

 

 

Basic

115,616

 

107,752

 

113,700

 

107,566

 

Diluted

115,616

 

109,239

Back

Subscribe to the BAM Newsletter

Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.

Subscribe